E-Prescribing Market Report 2025

The e-prescribing market size has grown exponentially in recent years. It will grow from $2.67 billion in 2024 to $3.32 billion in 2025 at a compound annual growth rate (CAGR) of 24.6%. The growth in the historic period can be attributed to regulatory mandates, medication errors reduction, improved patient safety, enhanced prescription workflow, increased prescriber efficiency.

The e-prescribing market size is expected to see exponential growth in the next few years. It will grow to $8.22 billion in 2029 at a compound annual growth rate (CAGR) of 25.4%. The growth in the forecast period can be attributed to growing telemedicine sector, personalized medicine, prescription drug monitoring programs, medicationTherapy management, global e-prescribing initiatives. Major trends in the forecast period include interoperability and health information exchange, medication reconciliation, electronic prior authorization, medication adherence tools, erx for controlled substances, ai-driven alerts and decision support.

The e-prescribing market is poised for growth, primarily driven by an increased emphasis on reducing medical errors. Medical errors, avoidable adverse effects of medical care, have been significantly mitigated by e-prescribing, particularly in addressing issues arising from illegible physician handwriting. Notably, in May 2023, the National Library of Medicine reported that medical errors in hospitals and clinics contribute to the deaths of approximately 100,000 people annually in the United States. The imperative to minimize such errors is a key factor propelling the expansion of the e-prescribing market.

The e-prescribing market is anticipated to experience substantial growth with the increasing adoption of telehealth and telemedicine. Telehealth, leveraging telecommunications technology for remote healthcare services, and telemedicine, specifically enabling remote clinical consultations, synergize with e-prescribing to streamline prescription processes, enhance efficiency, and boost patient engagement. The integration of e-prescribing with telehealth platforms allows healthcare providers to electronically transmit prescriptions to pharmacies, reducing errors, enhancing patient safety, and providing convenient access to medications. Notably, according to the Centers for Disease Control and Prevention in October 2022, 37% of adults utilized telemedicine within the preceding 12 months in 2021. This surge in telehealth adoption is a key driver for the anticipated growth of the e-prescribing market.

A significant trend in the e-prescribing market is the technological transformation in healthcare. Leading companies in the sector are actively pursuing the development of innovative technological solutions to fortify their market position. A notable example is Change Healthcare, a US-based healthcare technology company, which, in April 2022, introduced InterQual 2022. This latest edition of their clinical decision support solution incorporates updated criteria for emergent trends, streamlined and interactive workflows, and artificial intelligence (AI) for proactive insights and efficiency. The integration of unbiased and peer-reviewed criteria demonstrates a commitment to advancing technology within the e-prescribing landscape.

Prominent players in the e-prescribing market are actively engaged in the development of novel solutions for e-prescribing networks, positioning themselves strategically to secure a competitive advantage. An e-prescribing network serves as a digital platform facilitating the electronic exchange of prescription information among healthcare professionals, pharmacies, and payers. In a notable development in March 2022, First Databank Inc., a US-based healthcare company, introduced FDB Vela, a cloud-native electronic prescribing network. This innovative platform enables seamless communication of critical medication prescription information, benefits verification, and clinical decision support across diverse healthcare stakeholders, including prescribers, payers, pharmacies, and technology partners. FDB Vela emphasizes accessibility, easy onboarding, and advanced functionalities, offering a non-exclusive and straightforward avenue for participants to streamline the prescribing and fulfillment processes. This approach aims to enhance patient care and foster collaborative innovation within the healthcare industry.

In March 2023, PRN Software, LLC, a U.S.-based healthcare software company, acquired Bravado Health for an undisclosed amount. This acquisition allows PRN Software to expand its ePrescribing solutions, enhance patient safety and compliance, drive innovation and growth, and provide better support for healthcare providers. Bravado Health is a U.S.-based digital health technology company that improves patient care by integrating e-prescribing into its digital health platform.

Major companies operating in the e-prescribing market include Epic Systems Corporation, Allscripts Healthcare Solutions Inc., NextGen Healthcare Inc., Athenahealth, Henry Schein Inc., Computer Programs and Systems Inc., DrFirst.com Inc., Surescripts, Medical Information Technology, Change Healthcare, Health Fusion Inc., eMDs Inc., Cerner Corporation, Practice Fusion Inc., eClinicalWorks LLC, Greenway Health LLC, AdvancedMD Inc., Kareo Inc., PracticeSuite Inc., Advanced Data Systems Corporation, Aprima Medical Software Inc., Compulink Healthcare Solutions, CureMD Healthcare, MacPractice Inc., Medsphere Systems Corporation, Modernizing Medicine Inc., NueMD LLC, Office Ally Inc., Optum Inc., PatientNOW Inc., protected cell company, Sevocity Inc.

E-prescribing is a technological system that facilitates the electronic creation and transmission of prescriptions from healthcare providers, such as physicians, to participating pharmacies. This method eliminates the need for handwritten or faxed prescriptions and enables a more efficient and secure process.

In the realm of e-prescribing, components are broadly categorized into solutions and services. Services, in this context, denote intangible, non-physical elements within the economy, distinct from tangible goods. Deployment of e-prescribing systems can take place through web-based, cloud-based, or on-premise approaches. The end-users of e-prescribing systems include hospitals, office-based physicians, and pharmaceutical entities.

The e-prescribing market research report is one of a series of new reports that provides e-prescribing market statistics, including e-prescribing industry global market size, regional shares, competitors with an e-prescribing market share, detailed e-prescribing market segments, market trends and opportunities, and any further data you may need to thrive in the e-prescribing industry. This e-prescribing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

North America was the largest region in the e-prescribing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the e-prescribing market during the forecast period. The regions covered in the global e-prescribing market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the e-prescribing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The e-prescribing market consists of sales of software and services related to software. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.